325 related articles for article (PubMed ID: 18721168)
1. Improved treatment satisfaction but no difference in metabolic control when using continuous subcutaneous insulin infusion vs. multiple daily injections in children at onset of type 1 diabetes mellitus.
Skogsberg L; Fors H; Hanas R; Chaplin JE; Lindman E; Skogsberg J
Pediatr Diabetes; 2008 Oct; 9(5):472-9. PubMed ID: 18721168
[TBL] [Abstract][Full Text] [Related]
2. Continuous subcutaneous insulin infusion vs modern multiple injection regimens in type 1 diabetes: an updated meta-analysis of randomized clinical trials.
Pala L; Dicembrini I; Mannucci E
Acta Diabetol; 2019 Sep; 56(9):973-980. PubMed ID: 30945047
[TBL] [Abstract][Full Text] [Related]
3. Comparison of a multiple daily insulin injection regimen (basal once-daily glargine plus mealtime lispro) and continuous subcutaneous insulin infusion (lispro) in type 1 diabetes: a randomized open parallel multicenter study.
Bolli GB; Kerr D; Thomas R; Torlone E; Sola-Gazagnes A; Vitacolonna E; Selam JL; Home PD
Diabetes Care; 2009 Jul; 32(7):1170-6. PubMed ID: 19389820
[TBL] [Abstract][Full Text] [Related]
4. Glycemic patterns detected by continuous subcutaneous glucose sensing in children and adolescents with type 1 diabetes mellitus treated by multiple daily injections vs continuous subcutaneous insulin infusion.
Weintrob N; Schechter A; Benzaquen H; Shalitin S; Lilos P; Galatzer A; Phillip M
Arch Pediatr Adolesc Med; 2004 Jul; 158(7):677-84. PubMed ID: 15237068
[TBL] [Abstract][Full Text] [Related]
5. Recovery of hypoglycemia awareness in long-standing type 1 diabetes: a multicenter 2 × 2 factorial randomized controlled trial comparing insulin pump with multiple daily injections and continuous with conventional glucose self-monitoring (HypoCOMPaSS).
Little SA; Leelarathna L; Walkinshaw E; Tan HK; Chapple O; Lubina-Solomon A; Chadwick TJ; Barendse S; Stocken DD; Brennand C; Marshall SM; Wood R; Speight J; Kerr D; Flanagan D; Heller SR; Evans ML; Shaw JA
Diabetes Care; 2014 Aug; 37(8):2114-22. PubMed ID: 24854041
[TBL] [Abstract][Full Text] [Related]
6. A clinical trial of continuous subcutaneous insulin infusion versus multiple daily injections in older adults with type 2 diabetes.
Herman WH; Ilag LL; Johnson SL; Martin CL; Sinding J; Al Harthi A; Plunkett CD; LaPorte FB; Burke R; Brown MB; Halter JB; Raskin P
Diabetes Care; 2005 Jul; 28(7):1568-73. PubMed ID: 15983302
[TBL] [Abstract][Full Text] [Related]
7. IMPROVED HBA1C, TOTAL DAILY INSULIN DOSE, AND TREATMENT SATISFACTION WITH INSULIN PUMP THERAPY COMPARED TO MULTIPLE DAILY INSULIN INJECTIONS IN PATIENTS WITH TYPE 2 DIABETES IRRESPECTIVE OF BASELINE C-PEPTIDE LEVELS.
Vigersky RA; Huang S; Cordero TL; Shin J; Lee SW; Chhabra H; Kaufman FR; Cohen O;
Endocr Pract; 2018 May; 24(5):446-452. PubMed ID: 29847166
[TBL] [Abstract][Full Text] [Related]
8. Continuous subcutaneous insulin infusion and multiple dose of insulin regimen display similar patterns of blood glucose excursions in pediatric type 1 diabetes.
Alemzadeh R; Palma-Sisto P; Parton EA; Holzum MK
Diabetes Technol Ther; 2005 Aug; 7(4):587-96. PubMed ID: 16120030
[TBL] [Abstract][Full Text] [Related]
9. Continuous subcutaneous insulin infusion versus multiple daily injections in children and young people at diagnosis of type 1 diabetes: the SCIPI RCT.
Blair J; McKay A; Ridyard C; Thornborough K; Bedson E; Peak M; Didi M; Annan F; Gregory JW; Hughes D; Gamble C
Health Technol Assess; 2018 Aug; 22(42):1-112. PubMed ID: 30109847
[TBL] [Abstract][Full Text] [Related]
10. A comparison of multiple daily insulin therapy with continuous subcutaneous insulin infusion therapy in adolescents with type 1 diabetes mellitus: a single-center experience from Turkey.
Abaci A; Atas A; Unuvar T; Demir K; Bober E; Büyükgebiz A
J Pediatr Endocrinol Metab; 2009 Jun; 22(6):539-45. PubMed ID: 19694201
[TBL] [Abstract][Full Text] [Related]
11. Continuous subcutaneous insulin infusion. A new way to lower risk of severe hypoglycemia, improve metabolic control, and enhance coping in adolescents with type 1 diabetes.
Boland EA; Grey M; Oesterle A; Fredrickson L; Tamborlane WV
Diabetes Care; 1999 Nov; 22(11):1779-84. PubMed ID: 10546007
[TBL] [Abstract][Full Text] [Related]
12. OpT2mise: a randomized controlled trial to compare insulin pump therapy with multiple daily injections in the treatment of type 2 diabetes-research design and methods.
Aronson R; Cohen O; Conget I; Runzis S; Castaneda J; de Portu S; Lee S; Reznik Y;
Diabetes Technol Ther; 2014 Jul; 16(7):414-20. PubMed ID: 24735134
[TBL] [Abstract][Full Text] [Related]
13. Does treatment with an insulin pump improve glycaemic control in children and adolescents with type 1 diabetes? A retrospective case-control study.
Brorsson AL; Viklund G; Örtqvist E; Lindholm Olinder A
Pediatr Diabetes; 2015 Nov; 16(7):546-53. PubMed ID: 25327782
[TBL] [Abstract][Full Text] [Related]
14. Glycemic Outcomes in Adults With T1D Are Impacted More by Continuous Glucose Monitoring Than by Insulin Delivery Method: 3 Years of Follow-Up From the COMISAIR Study.
Šoupal J; Petruželková L; Grunberger G; Hásková A; Flekač M; Matoulek M; Mikeš O; Pelcl T; Škrha J; Horová E; Škrha J; Parkin CG; Svačina Š; Prázný M
Diabetes Care; 2020 Jan; 43(1):37-43. PubMed ID: 31530663
[TBL] [Abstract][Full Text] [Related]
15. Comparison between a multiple daily insulin injection regimen (basal once-daily glargine plus mealtime lispro) and continuous subcutaneous insulin infusion (lispro) using continuous glucose monitoring in metabolically optimized type 1 diabetes patients: A randomized open-labelled parallel study.
Ruiz-de-Adana MS; Dominguez-Lopez ME; Gonzalez-Molero I; Machado A; Martin V; Cardona I; de-la-Higuera M; Tapia MJ; Soriguer F; Anarte MT; Rojo-Martínez G
Med Clin (Barc); 2016 Mar; 146(6):239-46. PubMed ID: 26656958
[TBL] [Abstract][Full Text] [Related]
16. Does the timing of insulin pump therapy initiation after type 1 diabetes onset have an impact on glycemic control?
Shalitin S; Lahav-Ritte T; Lebenthal Y; Devries L; Phillip M
Diabetes Technol Ther; 2012 May; 14(5):389-97. PubMed ID: 22283639
[TBL] [Abstract][Full Text] [Related]
17. Continuous subcutaneous insulin infusion versus multiple daily injection regimens in children and young people at diagnosis of type 1 diabetes: pragmatic randomised controlled trial and economic evaluation.
Blair JC; McKay A; Ridyard C; Thornborough K; Bedson E; Peak M; Didi M; Annan F; Gregory JW; Hughes DA; Gamble C;
BMJ; 2019 Apr; 365():l1226. PubMed ID: 30944112
[TBL] [Abstract][Full Text] [Related]
18. Comparison of continuous subcutaneous insulin infusion and multiple daily injection regimens in children with type 1 diabetes: a randomized open crossover trial.
Weintrob N; Benzaquen H; Galatzer A; Shalitin S; Lazar L; Fayman G; Lilos P; Dickerman Z; Phillip M
Pediatrics; 2003 Sep; 112(3 Pt 1):559-64. PubMed ID: 12949284
[TBL] [Abstract][Full Text] [Related]
19. Comparison of continuous subcutaneous insulin infusion (CSII) and multiple daily injections (MDI) in paediatric Type 1 diabetes: a multicentre matched-pair cohort analysis over 3 years.
Jakisch BI; Wagner VM; Heidtmann B; Lepler R; Holterhus PM; Kapellen TM; Vogel C; Rosenbauer J; Holl RW;
Diabet Med; 2008 Jan; 25(1):80-5. PubMed ID: 18199134
[TBL] [Abstract][Full Text] [Related]
20. Continuous subcutaneous insulin infusion therapy: effects on quality of life.
Scheidegger U; Allemann S; Scheidegger K; Diem P
Swiss Med Wkly; 2007 Aug; 137(33-34):476-82. PubMed ID: 17990132
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
